Skip to Main Content

Paper Details

Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenograft models of metastatic colorectal cancer.
Int J Cancer
5
2020
Author NameAffiliation
Andrea Bertottiand Clinical Trials Coordination, Candiolo Cancer Institute Fondazione del Piemonte per l'Oncologia IRCCS
Andrea BertottiUniversity of Turin Medical School
Livio Trusolinoand Clinical Trials Coordination, Candiolo Cancer Institute Fondazione del Piemonte per l'Oncologia IRCCS
Livio TrusolinoUniversity of Turin Medical School
  • 1 - 4

Datasets

Release 1.2